14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 11, 2024 Sell 54 Cline Christopher R. Common Stock
Feb 01, 2024 Sell 9 106 Dube Eric M Common Stock
Feb 01, 2024 Sell 10 016 Dube Eric M Common Stock
Feb 01, 2024 Sell 2 174 Rote William E. Common Stock
Feb 01, 2024 Sell 2 590 Rote William E. Common Stock
Feb 01, 2024 Sell 2 820 Calvin Sandra Common Stock
Feb 01, 2024 Sell 2 174 Reed Elizabeth E Common Stock
Feb 01, 2024 Sell 2 590 Reed Elizabeth E Common Stock
Feb 01, 2024 Sell 4 195 Heerma Peter Common Stock
Feb 01, 2024 Sell 2 174 Inrig Jula Common Stock
Feb 01, 2024 Sell 3 818 Cline Christopher R. Common Stock
Jan 31, 2024 Buy 135 000 Dube Eric M Common Stock
Jan 31, 2024 Buy 360 000 Dube Eric M Employee stock option (right to buy)
Jan 31, 2024 Buy 25 000 Rote William E. Common Stock
Jan 31, 2024 Buy 65 000 Rote William E. Employee stock option (right to buy)
Jan 31, 2024 Buy 1 000 Calvin Sandra Common Stock
Jan 31, 2024 Buy 12 500 Calvin Sandra Common Stock
Jan 31, 2024 Buy 25 000 Calvin Sandra Employee stock option (right to buy)
Jan 31, 2024 Buy 25 000 Reed Elizabeth E Common Stock
Jan 31, 2024 Buy 65 000 Reed Elizabeth E Employee stock option (right to buy)
Jan 31, 2024 Buy 25 000 Heerma Peter Common Stock
Jan 31, 2024 Buy 65 000 Heerma Peter Employee stock option (right to buy)
Jan 31, 2024 Buy 91 000 Inrig Jula Employee stock option (right to buy)
Jan 31, 2024 Buy 25 000 Inrig Jula Common Stock
Jan 31, 2024 Buy 25 000 Cline Christopher R. Common Stock
Jan 31, 2024 Buy 65 000 Cline Christopher R. Employee stock option (right to buy)
Jan 23, 2024 Sell 2 062 Reed Elizabeth E Common Stock
Jan 23, 2024 Sell 7 873 Dube Eric M Common Stock
Jan 23, 2024 Sell 853 Cline Christopher R. Common Stock
Jan 23, 2024 Sell 2 062 Rote William E. Common Stock
Jan 23, 2024 Sell 910 Calvin Sandra Common Stock
Jan 23, 2024 Sell 1 559 Heerma Peter Common Stock
Jan 04, 2024 Sell 440 Inrig Jula Common Stock
Jan 03, 2024 Sell 2 069 Inrig Jula Common Stock
Oct 03, 2023 Sell 3 091 Heerma Peter Common Stock
Sep 05, 2023 Sell 457 Cline Christopher R. Common Stock
Sep 05, 2023 Sell 1 815 Rote William E. Common Stock
Sep 05, 2023 Sell 1 815 Reed Elizabeth E Common Stock
Sep 05, 2023 Sell 4 455 Dube Eric M Common Stock
Aug 31, 2023 Buy 3 300 Rote William E. Common Stock
Aug 31, 2023 Buy 3 300 Reed Elizabeth E Common Stock
Aug 31, 2023 Buy 9 900 Dube Eric M Common Stock
May 17, 2023 Buy 4 500 Baynes Roy D. Common Stock
May 17, 2023 Buy 13 500 Baynes Roy D. Stock option (right to buy)
May 17, 2023 Buy 4 500 Poole Sandra Common Stock
May 17, 2023 Buy 13 500 Poole Sandra Stock option (right to buy)
May 17, 2023 Buy 4 500 Coughlin Timothy Common Stock
May 17, 2023 Buy 13 500 Coughlin Timothy Stock option (right to buy)
May 17, 2023 Buy 13 500 Williams Brinkley Ruth Stock option (right to buy)
May 17, 2023 Buy 4 500 Williams Brinkley Ruth Common Stock
May 17, 2023 Buy 4 500 Meckler Jeffrey A Common Stock
May 17, 2023 Buy 13 500 Meckler Jeffrey A Stock option (right to buy)
May 17, 2023 Buy 4 500 Orwin John A Common Stock
May 17, 2023 Buy 13 500 Orwin John A Stock option (right to buy)
May 17, 2023 Buy 4 500 Lyons Gary A Common Stock
May 17, 2023 Buy 13 500 Lyons Gary A Stock option (right to buy)
May 17, 2023 Buy 4 500 Bruhn Suzanne Louise Common Stock
May 17, 2023 Buy 13 500 Bruhn Suzanne Louise Stock option (right to buy)
May 17, 2023 Buy 4 500 Squarer Ron Common Stock
May 17, 2023 Buy 13 500 Squarer Ron Stock option (right to buy)
May 11, 2023 Sell 122 Calvin Sandra Common Stock
May 10, 2023 Sell 455 Cline Christopher R. Common Stock
May 10, 2023 Sell 825 Reed Elizabeth E Common Stock
May 10, 2023 Sell 825 Rote William E. Common Stock
May 10, 2023 Sell 436 Calvin Sandra Common Stock
Apr 11, 2023 Sell 47 Cline Christopher R. Common Stock
Feb 02, 2023 Sell 360 Calvin Sandra Common Stock
Feb 01, 2023 Sell 2 590 Reed Elizabeth E Common Stock
Feb 01, 2023 Sell 2 590 Rote William E. Common Stock
Feb 01, 2023 Sell 1 779 Heerma Peter Common Stock
Feb 01, 2023 Sell 1 588 Cline Christopher R. Common Stock
Feb 01, 2023 Sell 8 196 Dube Eric M Common Stock
Feb 01, 2023 Sell 1 671 Calvin Sandra Common Stock
Jan 31, 2023 Buy 20 250 Reed Elizabeth E Common Stock
Jan 31, 2023 Buy 54 500 Reed Elizabeth E Employee stock option (right to buy)
Jan 31, 2023 Buy 6 750 Reed Elizabeth E Performance-based restricted stock units
Jan 31, 2023 Buy 20 250 Rote William E. Common Stock
Jan 31, 2023 Buy 54 500 Rote William E. Employee stock option (right to buy)
Jan 31, 2023 Buy 6 750 Rote William E. Performance-based restricted stock units
Jan 31, 2023 Buy 20 250 Heerma Peter Common Stock
Jan 31, 2023 Buy 54 500 Heerma Peter Employee stock option (right to buy)
Jan 31, 2023 Buy 6 750 Heerma Peter Performance-based restricted stock units
Jan 31, 2023 Buy 54 500 Cline Christopher R. Employee stock option (right to buy)
Jan 31, 2023 Buy 20 250 Cline Christopher R. Common Stock
Jan 31, 2023 Buy 6 750 Cline Christopher R. Performance-based restricted stock units
Jan 31, 2023 Buy 54 500 Inrig Jula Employee stock option (right to buy)
Jan 31, 2023 Buy 20 250 Inrig Jula Common Stock
Jan 31, 2023 Buy 6 750 Inrig Jula Performance-based restricted stock units
Jan 31, 2023 Buy 260 000 Dube Eric M Employee stock option (right to buy)
Jan 31, 2023 Buy 97 500 Dube Eric M Common Stock
Jan 31, 2023 Buy 32 500 Dube Eric M Performance-based restricted stock units
Jan 31, 2023 Buy 10 000 Calvin Sandra Common Stock
Jan 31, 2023 Buy 20 000 Calvin Sandra Employee stock option (right to buy)
Jan 25, 2023 Sell 192 Calvin Sandra Common Stock
Jan 24, 2023 Sell 905 Calvin Sandra Common Stock
Jan 24, 2023 Sell 2 062 Rote William E. Common Stock
Jan 24, 2023 Sell 2 062 Reed Elizabeth E Common Stock
Jan 24, 2023 Sell 6 442 Dube Eric M Common Stock
Jan 24, 2023 Sell 852 Cline Christopher R. Common Stock
Jan 24, 2023 Sell 1 550 Heerma Peter Common Stock
INSIDER POWER
86.111
Last 100 transactions
Buy: 2 015 500 | Sell: 106 721 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 86.111.

In total, the insiders bought 2 015 500 and sold 106 721 TVTX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Travere Therapeutics, Inc.

Travere Therapeutics. Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzy... TVTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT